跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LY-1
首页
药物
LY-1
LY-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Single-stranded oligonucleotide
US 11555188 B2
申请人: NISSAN CHEMICAL CORP
优先权: 2017
CN
EP
US
WO
4 件公开
METHODS OF DELIVERING THERAPEUTIC AGENTS, AND LIPID COMPOSITIONS
EP 4637825 A4
申请人: FUJIFILM CORP
优先权: 2022
CN
EP
US
WO
4 件公开
Tricyclic heterocyclic compounds as phosphoinositide 3-kinase inhibitors
US 11708378 B2
申请人: CONVALIFE SHANGHAI CO LTD
优先权: 2014
CN
US
2 件公开
ORGANIC ELECTROLUMINESCENT COMPOUND, HOST MATERIALS, AND LIGHT-EMITTING DEVICE AND LIGHT-EMITTING APPARATUS COMPRISING SAME
WO 2025156843 A1
申请人: JILIN OLED OPTICAL AND ELECTRONIC MAT CO LTD
优先权: 2024
CN
WO
2 件公开
Mammalian common lymphoid progenitor cell
US 7297329 B2
申请人: UNIV LELAND STANFORD JUNIOR
优先权: 2005
US
2 件公开
Use of the spin crossover complex [mx+(LY)HW]AN)Z as a magnetic resonance imaging contrast agent
US 8802055 B2
申请人: RAJADURAI CHANDRASEKAR
优先权: 2007
US
2 件公开
Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof
US 2006281672 A1
申请人: HART DEREK N J
优先权: 2002
US
A method of treating an acute vascular disorder
CN 101378762 A
申请人: PANTARHEI BIOSCIENCE BV
优先权: 2006
CN
Co-Crystals of Calixarenes and Biologically Active Molecules
US 2009233941 A1
申请人: CENTRE NAT RECH SCIENT
优先权: 2006
US
Sulfonium compound
CN 101125824 B
申请人: SUMITOMO CO LTD
优先权: 2006
CN
第 1 / 3 页
上一页
下一页
药物
反馈